Editorial Article: Are Two Antibodies Better than One?

Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails. Read the original SelectScience article here   As a senior staff scientist at...

Immuno-Oncology: Pushing the frontier of discovery through Advanced High Throughput Flow Cytometry

Immuno-oncology (IO) is increasingly prized as an effective therapy in cancer management.  The field encompasses a number of approaches with one common thread: they harness the body’s own immune system...

Editorial Article: Personalized Adoptive T Cell Therapy: A New, Rational Approach to Immunotherapy

A small team of biotech scientists is targeting patient specific ‘neoantigens’ to improve response to adoptive T cell therapy in acute myeloid leukemia (AML) Based in San Diego, Alison Tarke...

Editorial Article: From Whole Well to Single Cell – Enhancing the Development of Cancer Biosimilars with Advanced Flow Cytometry

In this interview with SelectScience scientists, Ben Tyrell and Katie Chapple, reveal how plate-based flow cytometry is advancing cancer biosimilar development through single-cell analysis. Biosimilars are large, complex biological therapies...

Antibody Screening Tools – Streamline Your Antibody Screening Workflow

Helping researchers identify, characterize and investigate new antibody candidates fuels the growing demand for therapeutic antibodies. Please give an overview of the most important advancements in this field. Biologics, in...

The Trouble with ELISA

Development of the enzyme-linked immunosorbent assay (ELISA) in the 1970s was a great leap forward in biomedical research. ELISA assays are so valuable that they are still used today in...

Want to learn more or request a demo?

Click Here